Cardiometabolic Medicine
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia. These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
ADVANCES IN CV PRIMARY PREVENTION: CONTEXT FOR NEW DATA FROM ADA23
1b) Patients with #diabetes are at substantially increased risk of #CV disease, often in association with hyperlipidemia #HL. Therefore it's no...
Live Tweetorial From ADA23 On Advances In Management Of Hyperlipidemia
1b) Patients with #diabetes #PWDs are of course at substantially increased risk of #CV disease, often in association with hyperlipidemia #HL....
Continuing the Conversation: EACVI23 Symposium on Optimizing Echocardiographic and CMR Assessment in the Diagnosis and Management of HCM
1b) Our all-star distinguished faculty includes Prof Thor Edvardsen @ThorEdvardsen 🇳🇴, Assoc Prof @unimib Denisa Muraru @denisamuraru 🇮🇹, & Prof...
Time in Range in Diabetes: In Canada, an Endocrinologist and a Family Doc Discuss
1b) Hence we welcome2⃣ expert faculty from Canada: Ilana Halperin @ilanajhalperin, academic endocrinologist at @sunnybrook and @uoftmedicine, and...
Optimizing Echocardiographic and CMR Assessment in the Diagnosis and Management of HCM
1b) Our all-star distinguished faculty includes Prof Thor Edvardsen @ThorEdvardsen 🇳🇴, Assoc Prof @unimib Denisa Muraru @denisamuraru 🇮🇹, & Prof...
Clinical trial data for nonsteroidal MRA therapy in patients with advancing CKD in the setting of T2D
2) Christos Argyropoulos MD, PhD @ChristosArgyrop is Division Chief, Nephrology @UNMHSC.#FOAMed #nephtwitter #cardiotwitter @MedTweetorials...
LIVE TWEETORIAL FROM NLA23 ON ADVANCES IN MANAGEMENT OF HYPERLIPIDEMIA
1b) Dr. Taub is a clinician/scientist and is a frequent contributor to our #accredited programs. She is the founding director of the Step Family...
HFpEF Treatment Algorithm
1b) .@HFpEF will be sharing the algorithm he uses to treat #HFpEF based on evidence we have thus far and his anecdotal experience treating patients...
Screening for CKD in Patients with T2D: Microalbuminuria
2) Christos Argyropoulos MD, PhD @ChristosArgyrop is Division Chief, Nephrology @UNMHSC. #CKD is chronic #kidneydisease, #ESKD is end-stage kidney...
The Relationship of Natriuresis with Decongestion & Clinical Outcomes after Diuretic Therapy in Acute Heart Failure
2) Our expert author is Frederik H. Verbrugge @FH_Verbrugge Cardiology & ICU @HeartBrussels @UZBrussel | Research @MayoClinicCV | Deputy Editor...
@Cardiomet_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.